Signal transducer and activator of transcription 3 (STAT3) is a potential drug target for chemotherapy. Cryptotanshinone (CTS) was identified as a potent STAT3 inhibitor, while the effect of other tanshinones remains unknown. In this study, the influence of eight tanshinones on STAT3 activity was initially screened and isocryptotanshinone (ICTS) significantly inhibited STAT3 activity in a dual-luciferase assay. ICTS inhibited the constitutive and inducible phosphorylation of STAT3 at Y705 without affecting the phosphorylation of STAT3 at S727 in A549 lung cancer cells. Furthermore, ICTS inhibited the nuclear translocation of STAT3. Compared with CTS, ICTS exhibited a stronger inhibitory effect on STAT3 phosphorylation and on A549 cytotoxicity. ICTS induced autophagy as evidenced by the accumulation of autophagic vacuoles and the increased expression of LC3 protein and autophagosomes. ICTS-induced cell death was partially reversed by the autophagy inhibitor chloroquine. The docking assay predicted that both ICTS and CTS bind the SH2 domain of STAT3. ICTS formed hydrogen bonds and pi-pi interaction with the nearby amino acid residues of Lys591, Arg609, and Ser636. These findings suggested that ICTS, a natural compound, is a potent STAT3 inhibitor. ICTS induced apoptosis and pro-death autophagy in A549 cells.
Isocryptotanshinone, a STAT3 inhibitor, induces apoptosis and pro-death autophagy in A549 lung cancer cells

Introduction
The signal transducer and activator of transcription (STAT) family comprises transcriptional factors that transduce extracellular signals and regulate the transcription of target genes. The STAT family includes seven members, namely, STAT1 to STAT4, STAT5a, STAT5b, and STAT6 [Wang and Levy, 2012] , which share similar structures of five domains [Yu et al., 2009] . Among these members, STAT3 is widely investigated and is considered an oncogene that is constitutively activated in most cancer types [Bromberg et al., 1999] . STAT3 is closely related to tumor initiation, promotion, and progression by regulating cancer cell survival, proliferation, cell cycle progression, metastasis, metabolism, and angiogenesis [Niu et al., 2002] .
STAT3 is activated by phosphorylation at several sites, such as Y705, S727, S694, K685, and K140. Phosphorylation on Y705 and S727 sites is extensively studied [Sellier et al., 2013] . The Y705 of STAT3 is phosphorylated by non-receptor tyrosine kinases, such as JAK and members of the Src kinase family. The Y705 phosphorylation is also induced by cytokines, such as IL-6, IL-10, and IL-22 [Yu et al., 2009] . The phosphorylated STAT3 at Y705 (p-STAT3(Y705)) forms a homogenous or heterogeneous dimer, which is subsequently translocated to the nucleus to regulate the transcription of target genes [Sellier et al., 2013] . In contrast, S727 is generally phosphorylated by receptor tyrosine kinases (RTKs), which mainly belong to the mitogen-activated protein kinase (MAPK) family, and is then translocated to mitochondria and performs in mitochondria function [Macias et al., 2014] . Given the close relationship of STAT3 with inflammation, tumor transformation, and J U S T
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malignancy, STAT3 is considered as a potential drug target for cancer chemotherapy [Inghirami et al., 2005; Jing and Tweardy, 2005] .
Natural products are the major resources of new drug research and development.
Numerous natural products derived from natural herbs, such as traditional Chinese medicine, display STAT3-dependent inhibitory effect on lung cancer cells. These natural products include quercetin [Mukherjee and Khuda-Bukhsh, 2015] , xanthatin [Tao et al., 2013] , butein [Pandey et al., 2009] , withaferin A [Lee et al., 2010] , and cryptotanshinone (CTS) [Shin et al., 2009] . CTS is a lipophilic abietane diterpene that is isolated from the Chinese herb Danshen (Salvia miltiorrhiza Bunge). CTS exhibits various pharmacological activities, such as antibacterial, antioxidant, and anti-inflammation. Recently, considerable attention has been focused on its anticancer activities [Chen et al., 2014a; Chen et al., 2011; Lu et al., 2013] , which are partially due to its inhibitory effect on STAT3 [Shin et al., 2009] . CTS belongs to a large family of tanshinones that are mainly isolated from Danshen. More than 40 similarly structured tanshinones, such as tanshinone IIA (Tan IIA), tanshinone IIB, isotanshinone IIA, neocryptotanshinone, tanshindiol A, isocyptotanshinone (ICTS), tanshinone I, and dihydrotanshinone, have been isolated and identified [Chen et al., 2014b] . However, the anticancer effects of most tanshinones, except for Tan IIA and CTS, were rarely reported. CTS ( Figure 1A ) was identified as a potent inhibitor of STAT3 through blocking the dimerization in DU145 prostate cancer cells [Shin et al., 2009] . Meanwhile, the effect of other tanshinones on STAT3 remains unclear. We have recently reported that ICTS ( Figure 1A ), a CTS analogue, inhibited breast cancer
MCF-7 cell proliferation by inducing apoptosis . In this study, we identified that ICTS is a potent STAT3 inhibitor, which induced apoptosis and pro-death autophagy in A549 cells.
MATERIALS AND METHODS
Reagents
Dihydrotanshinone I (1), tanshindiol A (2), 1,2-dehydrocryptotanshinone (3), isotanshinone IIA (5), Tan IIA (6), ICTS (7), and neocryptotanshinone (8) heat-inactivated FBS. Cell cultures were maintained at 37 °C under a humidified atmosphere of 5% CO 2 in an incubator.
MTT assay
Cells were cultured in 96-well plates at a density of 1 × 10 4 cells/well and treated with tanshinones (1-8) for 24 h. The cells were then co-incubated with MTT (1 mg/mL) for another 4 h and then added with DMSO (100 μL/well). Absorbance at 570 nm was measured using Wallac Victor3 (Perkin-Elmer, Inc.).
Dual-luciferase assay
A549 cells were seeded at a density of 3 × 10 5 cells in six-well plates overnight and co-transfected with 4 μg of pSTAT3-TA-Luc and pRL-TK (Promega) for 6 h with TurboFect transfection reagents. After incubation in fresh complete medium overnight, cells were trypsinized and seeded onto sterile, black-bottomed 48-well plates overnight. Cells were treated with either tanshinones (1-8) or 0.1% DMSO for 24 h and then induced with IL-6 (25 ng/mL) for 30 min. Cells were harvested in 20 μL passive lysis buffer, and luciferase activity was evaluated using the dual luciferase
reporter assay kit (Promega) on Wallac Victor3.
Western blotting
Equal amounts of proteins were loaded on 8% to 12% SDS-PAGE and transferred to PVDF membranes. Membranes were blocked in 5% nonfat dry milk dissolved in TBST and then incubated at 4 °C overnight with the primary antibodies (1:1000).
Afterward, the membranes were washed with TBST and subsequently incubated with a second antibody (1:10000) for 2 h. 
Detection of apoptosis
ICTS-induced apoptosis was measured using Annexin-V/7-AAD double stain assay, which was performed in accordance with the manufacturer's protocols. The results are displayed and analyzed with a flow cytometer (BD BioSciences).
Caspase 3/7 activity
Caspase 3/7 activities after ICTS treatment were detected using a Caspase-Glo™ 3/7 assay kit following the manufacturer's protocols.
MDC staining
A549 cells seeded in 96-well plates at a density of 1 × 10 5 cells/well were treated with ICTS (10 μM) for 6 h and then stained with MDC (10 μM) at 37 °C for 30 min.
Fluorescence was observed using a fluorescence microscope.
Transmission electron microscope (TEM) imaging
A549 cells were treated with ICTS (10 µM) for 24 h, and the formation of autophagosomes was visualized under a TEM as previously described [Tang et al., 2014] .
Molecular modeling and docking
To understand why ICTS and CTS perform distinct functions in the inhibition of STAT3 activity, we established a molecular model. The crystal structure of STAT3 at 2.25 Å resolution [Becker et al., 1998 ] was obtained from the Protein Data Bank (PDB ID: 1BG1) and used for this modeling. Docking of ICTS and CTS to the
binding site of STAT3 SH2 domain was performed in silico by employing the LibDock module in the Discover Studio 2.5 package [Chinthala et al., 2015; Xu et al., 2015] . Prior to docking, water molecules and binding DNA were removed, and the polar hydrogens and incomplete residues were added to the STAT3 model. The 3D structures of ICTS and CTS were constructed using the Prepare Ligands module. The binding pocket for ligand molecules was defined as STAT3 SH2 domain with a 14 Å radius from the center of the binding pocket.
Statistical analysis
Data are presented as means ± SD. Statistical data were analyzed with one-way ANOVA, followed by Tukey's post hoc test, using SPSS 16.0 statistical software (SPSS, Chicago, IL, USA). A P < 0.05 was considered significantly different.
J U S T A C C E P T E D
Results
Inhibitory effect of tanshinones on STAT3 activity and cell proliferation
The constitutive expression STAT3 and p-STAT3 in seven cancer cell lines was initially screened with Western blot. All the cells showed detectable levels of STAT3 expression. A549 and 95D cells present higher expression levels of p-STAT3 (Y705).
All cell lines demonstrated low expression of p-STAT3 (S727) except MDA-MB-231 cells ( Figure 1B ). As A549 cell line showed higher expression of both STAT3 and p-STAT3 (Y705), it was selected for further study. MTT assay showed that tanshinones significantly inhibited A549 proliferation and ICTS exhibited the strongest activity ( Figure 1C ). Western blot showed that six tanshinones (2, 3, 4, 5, 7, and 8) displayed inhibitory effect on p-STAT3 (Y705) expression ( Figure 1D ).
Dual-luciferase assay demonstrated that tanshinones significantly inhibited IL-6-induced STAT3 activity. CTS and ICTS exhibited the highest activities ( Figure   1E ).
ICTS inhibits the constitutive phosphorylation of STAT3 (Y705)
ICTS and CTS inhibited the constitutive STAT3 and p-STAT3 (Y705) expression in concentration- (Figure 2A ) and time-dependent ( Figure 2B ) manners.
Immunofluorescence showed that STAT3 and p-STAT3 (Y705) were mainly distributed in the cytoplasm and nucleus in untreated A549 cells, respectively.
However, the amount of STAT3 in the cytoplasm and p-STAT3 (Y705) in nucleus were dramatically decreased after ICTS treatment ( Figure 2C ). Figure 3C ).
ICTS suppresses STAT3 target genes
The expression of cell survival-related proteins (Bcl-2, Bcl-xL, survivin, Mcl-1) was dramatically attenuated by ICTS treatment in a time-dependent manner ( Figure 4A ).
Furthermore, the expression of both EGFR and JAK2 were significantly decreased after ICTS treatment in a concentration-dependent manner ( Figure 4B ).
ICTS induces apoptosis
ICTS and CTS significantly inhibited the proliferation of A549 ( Figure 5A ) and 95D
(
Figure 5B Figure 5D ). Caspase 3/7 activities increased by approximately 53 times that of the untreated group after ICTS (10 μM) treatment for 5 h ( Figure 5E ). Furthermore, the expression of cleaved PARP was dramatically increased.
ICTS induces pro-death autophagy
ICTS-induced cell death was enhanced by CQ co-treatment ( Figure 6A ). ICTS treatment dramatically increased the expression of LC3II in a time-dependent manner ( Figure 6B ), which was further increased by CQ co-treatment ( Figure 6C ).
Furthermore, ICTS treatment decreased the expression of p-AKT (Ser473), p-AKT
(Thr308), and p-mTOR (Ser2448) without affecting p62 ( Figure 6D ). MDC staining showed that ICTS treatment resulted in the accumulation of autophagic vacuoles ( Figure 6E ). TEM results showed that autolysosomes increased dramatically in ICTS-treated cells ( Figure 6F ).
ICTS binds to the SH2 domain of STAT3
Molecular docking between STAT3 and ICTS and CTS was performed by employing the LibDock module in the Discover Studio 2.5 package. LibDock score, absolute energy, and relative energy are summarized in Table 1 . The in silico molecular docking study results showed that ICTS and CTS exhibited well-established bonds with one or more amino acids in its active pocket. ICTS formed a number of hydrogen bonds and pi-pi interaction with nearby amino acid residues, including Lys591, Arg609, and Ser636. However, CTS only bonded with the Arg609 and Ser636 residues of STAT3, and the interaction was weaker than that with ICTS ( Figure 7 ).
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Discussion
CTS is a natural product that displayed anticancer effect in breast cancer [Zhou et al., 2014] , hepatoma [Park et al., 2014] , colon cancer , prostate cancer [Shin et al., 2009] , and lung cancer [Chen et al., 2014a] . Although its underlying mechanisms are not clearly clarified, the suppression of STAT3 was considered to paly import roles [Ge et al., 2015; Lu et al., 2013; Shin et al., 2009] . In this study, we reported that ICTS, a CTS analogue, is a potent STAT3 inhibitor. contributes to the cytotoxic effect of these tanshinones.
CTS is a potent STAT3 inhibitor in DU145 prostate cancer cells [Shin et al., 2009 ],
human glioma cell lines (T98G and U87) , SW480, HCT116, and LOVO colorectal cancer cells , and human mucoepidermoid carcinoma MC-3 cells [Yu et al., 2014b] . Activated STAT3 proteins undergo dimerization and then translocate into the nucleus, where the proteins bind to specific DNA sequences [Debnath et al., 2012] . Our immunofluorescence results showed that both total STAT3 and the nuclear translocation of p-STAT3 were inhibited by ICTS, In addition, CTS and ICTS showed similar cytotoxicity to A549 cells, which showed higher expression of STAT3. 95D cells with lower expression of STAT3 were less sensitive to ICTS and CTS. Along with the STAT3 activity assay, these results suggest that ICTS is a more potent STAT3 inhibitor than CTS.
Activation of STAT3 was regulated by upstream molecules, such as the JAK family of protein tyrosine kinases [Yu et al., 2014a] , growth factor receptors, such as EGFRs, FGFRs, HGFRs, PDGFRs, and VEGFRs [Debnath et al., 2012] . Notably, the levels of JAK2 and EGFR expression were also markedly decreased by ICTS, thereby possibly contributing to STAT3 inhibition. STAT3 as a nuclear transcriptional factor regulates the transcription of a series of downstream genes, which are involved in cell proliferation, survival, and apoptosis [Jarnicki et al., 2010] . ICTS treatment decreased the expression levels of Mcl-1, Bcl-2, Bcl-xL, and survivin. Furthermore, it J U S T
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substantially induced increase of caspase 3/7 activity, DNA fragmentation, and PARP cleavage. These data suggest the occurrence of apoptosis which was further confirmed by the Annexin-V/7-AAD double stain assay. This finding was consistent with our recent report, which stated that ICTS induced caspase-dependent apoptosis in MCF-7 breast cancer . Collectively, ICTS induced caspase-dependent apoptosis possibly through the inhibition of STAT3.
CTS induces autophagic cell death in HepG2 hepatoma [Park et al., 2014] and multidrug-resistant colon cancer SW620/Ad300 cells [Hu et al., 2015] . We also reported that CTS induced pro-death autophagy in A549 cells [Hao et al., 2015] . Here,
ICTS treatment induced accumulation of autophagic vacuoles and increased expression of LC3II. These findings suggested that ICTS regulates autophagy, which was further confirmed by TEM imaging. Enhanced LC3II by CQ suggested that ICTS may be an autophagy inducer. Downregulated expression of p-AKT and p-mTOR suggested that AKT/mTOR signaling pathway was involved in ICTS-induced autophagy. In addition, ICTS-induced cell death was reversed by CQ suggesting that, similar to CTS, ICTS induced pro-death autophagy.
CTS binds to the SH2 domain of STAT3 at the specific site where the Tyr705 residue interacts within the SH2 domain. It forms a number of hydrogen bonds with nearby amino acid residues, including Arg609 and Ile634 [Shin et al., 2009] . Here, we
show that ICTS also interact within the SH2 domain of STAT3. ICTS forms a number of hydrogen bonds and pi-pi interaction with nearby amino acid residues, including Lys591, Arg609, and Ser636. However, CTS only bonded with Arg609 and Ser636 of J U S T
STAT3. Thus, the interaction was weaker than that of ICTS, providing further evidence that ICTS is a more potent STAT3 inhibitor.
In summary, we identified that CTS analogue ICTS showed a more potent inhibitory effect on STAT3. ICTS inhibited A549 cells proliferation through caspase-dependent apoptosis and AKT/mTOR mediated pro-death autophagy.
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